Spot Trading’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$10.6M Sell
23,700
-19,700
-45% -$9.37M 0.18% 97
2017
Q2
$21.3M Buy
43,400
+34,800
+405% +$15.2M 0.42% 21
2017
Q1
$3.33M Buy
8,600
+8,200
+2,050% +$3.04M 0.11% 172
2016
Q4
$147K Sell
400
-2,500
-86% -$951K ﹤0.01% 2062
2016
Q3
$1.17M Sell
2,900
-12,500
-81% -$5.01M 0.02% 960
2016
Q2
$5.38M Sell
15,400
-5,000
-25% -$1.93M 0.09% 279
2016
Q1
$7.35M Buy
20,400
+18,800
+1,175% +$7.75M 0.13% 184
2015
Q4
$869K Sell
1,600
-2,100
-57% -$1.14M 0.01% 1553
2015
Q3
$1.72M Sell
3,700
-1,800
-33% -$967K 0.02% 1190
2015
Q2
$2.81M Hold
5,500
0.03% 928
2015
Q1
$2.48M Buy
5,500
+3,600
+189% +$1.53M 0.02% 964
2014
Q4
$779K Buy
1,900
+200
+12% +$78.7K ﹤0.01% 2048
2014
Q3
$613K Sell
1,700
-800
-32% -$268K ﹤0.01% 2419
2014
Q2
$706K Sell
2,500
-10,000
-80% -$2.96M ﹤0.01% 2407
2014
Q1
$3.75M Buy
12,500
+9,900
+381% +$3.05M 0.02% 1046
2013
Q4
$716K Sell
2,600
-5,800
-69% -$1.67M ﹤0.01% 2213
2013
Q3
$2.63M Buy
8,400
+6,200
+282% +$1.63M 0.02% 1178
2013
Q2
$495K Buy
+2,200
New +$512K ﹤0.01% 2448

Other funds holding REGN

Spot Trading's REGN Position: Q3 2017 in Review

Spot Trading opened a new position in Regeneron Pharmaceuticals (REGN) in Q3 2017: 1,919 shares worth $858K. The stake represents 0.01% of the portfolio and ranks #1276 among its holdings. This is a return to the name: Spot Trading previously reported a position in REGN as recently as Q3 2016.

Spot Trading first reported a position in REGN in Q2 2013 and has held it in 10 quarters since. The position peaked at $1.84M in Q2 2016. 605 funds tracked by Wall St. Rank hold REGN as of Q3 2017.

  • Spot Trading held 1,919 shares of Regeneron Pharmaceuticals worth $858K as of Q3 2017.
  • Regeneron Pharmaceuticals was a new Spot Trading position in Q3 2017.
  • Regeneron Pharmaceuticals made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1276 holding.
  • Spot Trading first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 10 quarters since.
  • Spot Trading's Regeneron Pharmaceuticals position peaked at $1.84M in Q2 2016.
  • 605 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.